Griebenow R, Pittrow DB, Weidinger G, Mutschler E
Antihypertensive efficacy and tolerability of a low-dose reserpine/thiazide combination compared to an ace- inhibitor in first-line treatment
11th Scientific Meeting, American Society of Hypertension
Am J Hypert (Apr) 9:119A 1996

A combination of reserpine (0.1 mg) and a thiazide diuretic (clopamid, 5 mg) was compared to enalapril (5 mg) in 127 hypertensives with diastolic blood pressure between 100 and 114 mmHg (average 156/104 mmHg). If diastolic BP remained above 90 mmHg after 3 weeks of treatment, the dose of medication was doubled and treatment continued for 3 additional weeks. The combination therapy lowered blood pressure more than the ACE inhibitor at both 3 weeks (-19.6/-17.0 v. -6.1/-9.5 mmHg, delta SBP/delta DBP, p <0.001) and 6 weeks (-23.5/-19.1 v. -10.2/-11.6 mmHg, p<0.001). There was no significant difference in the incidence of adverse events between the 2 treatments. The authors conclude that reserpine/diuretic is an effective, well- tolerated alternative to ACEI as initial treatment.

Comment: It would appear that antihypertensive drug treatment has come full circle. The early VA Trial experience employed the reserpine-diuretic approach and demonstrated both efficacy and safety. Unfortunately, a reported association of breast cancer with reserpine treatment, later proven false, seriously undermined confidence in reserpine's safety, and the subsequent introduction of novel agents, e.g., methyldopa, all but killed reserpine as an antihypertensive. The drug remains widely available in generic form, is amongst the least expensive antihypertensive medications and, as shown again in this study, is very effective when combined with a diuretic. The design of the study may overstate the difference in efficacy between the combination and the ACE inhibitor, as BP was measured 24 hours after dosing, and enalapril is known to have a poor peak/trough ratio at the dose used. (Alan Weder, M.D., University of Michigan)

To go back use the BACK button on your browser.
Otherwise click on the desired link to this article below:
11th Scientific Meeting, American Society of Hypertension
H: Drug therapy : Diuretics
H: Drug therapy : Sympatholytics